Market Overview

The Global Gastric Cancer Therapy Market was valued at USD 6,565.0 million in 2023 and is expected to reach USD 17,329.6 million by 2031 while growing at a CAGR of 12.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global gastric cancer therapy market growth. Gastric cancer originates from the growth of cells within the stomach, located in the upper middle part of the abdomen, just below the ribs. The stomach plays a vital role in breaking down and digesting food. Treatment options for gastric cancer vary depending on the disease's extent and may encompass radical surgery, chemotherapy, radiation therapy, and immunotherapy.

Continual progress in treatment modalities, encompassing surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, coupled with the increasing incidence of gastric cancer and a growing aging population, propels market expansion. However, the market's growth is impeded by high treatment costs and adverse treatment effects.

Furthermore, the global gastric cancer therapy industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Therapy Type Analysis

The Global Gastric Cancer Therapy Market is segmented among Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Surgery, based on Therapy Type. In 2023, Targeted Therapy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Gastric Cancer Therapy Market is segmented among Ambulatory Surgery Centers, Hospitals and Specialty Clinics, and Other End Users, based on End User. In 2023, Hospitals and Specialty Clinics accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Gastric Cancer Therapy Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Bristol-Myers Squibb Company, Celltrion Healthcare Co.,Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GSK plc, Imugene Limited, Novartis AG, Merck & Co. Inc., Otsuka Holdings Co. Ltd, Pfizer Inc., Sanofi S.A, and Astrazeneca.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Gastric Cancer Therapy Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Gastric Cancer Therapy Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Gastric Cancer Therapy Market Segmentation, By Therapy Type

• Global Gastric Cancer Therapy Market Share Analysis, By Therapy Type

• Global Gastric Cancer Therapy Market Growth Analysis, By Therapy Type

• Global Gastric Cancer Therapy Market Trends, By Therapy Type

o Chemotherapy

o Targeted Therapy

o Immunotherapy

o Radiation Therapy

o Surgery

6. Global Gastric Cancer Therapy Market Segmentation, By End User

• Global Gastric Cancer Therapy Market Share Analysis, By End User

• Global Gastric Cancer Therapy Market Growth Analysis, By End User

• Global Gastric Cancer Therapy Market Trends, By End User

o Ambulatory Surgery Centers

o Hospitals and Specialty Clinics

o Other End Users

7. Global Gastric Cancer Therapy Market Segmentation, By Region

• Global Gastric Cancer Therapy Market Share Analysis, By Region

• Global Gastric Cancer Therapy Market Growth Analysis, By Region

• Global Gastric Cancer Therapy Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Bristol-Myers Squibb Company*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Celltrion Healthcare Co.,Ltd

• Eli Lilly and Company

• F. Hoffmann-La Roche Ltd

• GSK plc

• Imugene Limited

• Novartis AG

• Merck & Co. Inc.

• Otsuka Holdings Co. Ltd

• Pfizer Inc.

• Sanofi S.A

• Astrazeneca

*Similar analysis will be provided for each company listed above.